Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2016, Article ID 1342028, 3 pages
http://dx.doi.org/10.1155/2016/1342028
Case Report

Recurrent Pericarditis, an Unexpected Effect of Adjuvant Interferon Chemotherapy for Malignant Melanoma

1Memorial Hospital of Rhode Island, Alpert Medical School of Brown University, Pawtucket, RI 02860, USA
2Kent Hospital, Warwick, RI 02886, USA

Received 25 March 2016; Revised 7 June 2016; Accepted 9 June 2016

Academic Editor: Gianluca Di Bella

Copyright © 2016 Farhan Ashraf et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. W. Troughton, C. R. Asher, and A. L. Klein, “Pericarditis,” The Lancet, vol. 363, no. 9410, pp. 717–727, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. D. H. Spodick, “Acute pericarditis: current concepts and practice,” The Journal of the American Medical Association, vol. 289, no. 9, pp. 1150–1153, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Permanyer-Miralda, J. Sagristá-Sauleda, and J. Soler-Soler, “Primary acute pericardial disease: a prospective series of 231 consecutive patients,” The American Journal of Cardiology, vol. 56, no. 10, pp. 623–630, 1985. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Itoh, T. Okanoue, F. Enjyo et al., “Elevated interleukin-6 and γ-globulin during interferon therapy of hepatitis B,” The American Journal of Gastroenterology, vol. 87, no. 10, pp. 1485–1487, 1992. View at Google Scholar · View at Scopus
  5. B. S. Edwards, J. A. Merritt, R. C. Fuhlbrigge, and E. C. Borden, “Low doses of interferon alpha result in more effective clinical natural killer cell activation,” The Journal of Clinical Investigation, vol. 75, no. 6, pp. 1908–1913, 1985. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Sonnenblick and A. Rosin, “Cardiotoxicity of interferon: a review of 44 cases,” Chest, vol. 99, no. 3, pp. 557–561, 1991. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Mansat-Krzyzanowska, B. Dréno, A. Chiffoleau, and P. Litoux, “Cardiovascular manifestations associated with interferon alfa-2A,” Annales de Medecine Interne, vol. 142, no. 8, pp. 576–581, 1991. View at Google Scholar · View at Scopus
  8. H. Teragawa, T. Hondo, H. Amano, F. Hino, and M. Ohbayashi, “Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C,” Japanese Heart Journal, vol. 37, no. 6, pp. 905–915, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Sacchi, H. Kantarjian, S. O'Brien, P. R. Cohen, S. Pierce, and M. Talpaz, “Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia,” Journal of Clinical Oncology, vol. 13, no. 9, pp. 2401–2407, 1995. View at Google Scholar · View at Scopus
  10. O. Benjamini, O. Kimhi, and M. Lishner, “Severe pleuropericarditis and cardiomyopathy induced by high dose interferon alpha-2b,” Israel Medical Association Journal, vol. 9, no. 6, pp. 486–487, 2007. View at Google Scholar · View at Scopus
  11. A. Boonen, R. W. Stockbrügger, and S. van der Linden, “Pericarditis after therapy with interferon-α for chronic hepatitis C,” Clinical Rheumatology, vol. 18, no. 2, pp. 177–179, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Nishio, T. Konndo, S. Okada, and M. Enchi, “Pericarditis and chronic inflammatory demyelinating polyneuropathy during therapy with pegylated interferon alfa-2a for chronic hepatitis C,” World Journal of Hepatology, vol. 2, no. 9, pp. 358–361, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Fava, M. Luoni, and S. Stioui, “Pericarditis during interferon-α therapy in chronic myelogenous leukemia,” Haematologica, vol. 81, no. 5, p. 484, 1996. View at Google Scholar · View at Scopus
  14. C. Popescu, V. Arama, and S. Gliga, “Acute pericarditis due to pegylated interferon alpha therapy for chronic HCV hepatitis—case report,” BMC Gastroenterology, vol. 11, article 30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Rauw, S. Ahmed, and T. Petrella, “Pericardial effusion and tamponade following interferon alpha treatment for locally advanced melanoma,” Medical Oncology, vol. 29, no. 2, pp. 1304–1307, 2012. View at Publisher · View at Google Scholar · View at Scopus